633 related articles for article (PubMed ID: 4031064)
1. Influence of obesity on the metabolism of apolipoprotein B in humans.
Egusa G; Beltz WF; Grundy SM; Howard BV
J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
[TBL] [Abstract][Full Text] [Related]
2. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
[TBL] [Abstract][Full Text] [Related]
3. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women.
Wolfe BM; Huff MW
J Clin Invest; 1989 Jan; 83(1):40-5. PubMed ID: 2910918
[TBL] [Abstract][Full Text] [Related]
5. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
7. Effects of low dosage progestin-only administration upon plasma triglycerides and lipoprotein metabolism in postmenopausal women.
Wolfe BM; Huff MW
J Clin Invest; 1993 Jul; 92(1):456-61. PubMed ID: 8326011
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
10. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
[TBL] [Abstract][Full Text] [Related]
11. In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T; Packard C
Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
[TBL] [Abstract][Full Text] [Related]
13. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
Demant T; Bedford D; Packard CJ; Shepherd J
J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
[TBL] [Abstract][Full Text] [Related]
15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
16. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
Briand F; Bailhache E; Andre A; Magot T; Krempf M; Nguyen P; Ouguerram K
Metabolism; 2008 Jul; 57(7):966-72. PubMed ID: 18555839
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.
Kesäniemi YA; Beltz WF; Grundy SM
J Clin Invest; 1985 Aug; 76(2):586-95. PubMed ID: 3861622
[TBL] [Abstract][Full Text] [Related]
18. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
Huff MW; Telford DE
Arteriosclerosis; 1989; 9(1):58-66. PubMed ID: 2912422
[TBL] [Abstract][Full Text] [Related]
19. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
20. Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
Sigurdsson G; Nicoll A; Lewis B
J Clin Invest; 1975 Dec; 56(6):1481-90. PubMed ID: 172533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
